Article info

Download PDFPDF
Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy

Authors

  • William M Stern Department of Clinical and Experimental Epilepsy, NIHR University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, UK Epilepsy Society, London, UK PubMed articlesGoogle scholar articles
  • Joel S Winston Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, UK Department of Neurophysiology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Elaine Murphy Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • J Helen Cross Institute of Child Health, UCL, London, UK PubMed articlesGoogle scholar articles
  • Josemir W Sander Department of Clinical and Experimental Epilepsy, NIHR University College London Hospitals Biomedical Research Centre, UCL Institute of Neurology, London, UK Epilepsy Society, London, UK Stichting Epilepsie Instellingen Nederland (SEIN), Netherlands, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr William M Stern, Clinical and Experimental Epilepsy, Institute of Neurology, 33 Queen Square, London WC1N 3BG, UK; williamstern{at}doctors.org.uk
View Full Text

Citation

Stern WM, Winston JS, Murphy E, et al
Guanidinoacetate methyltransferase (GAMT) deficiency: a rare but treatable epilepsy

Publication history

  • Received July 12, 2016
  • Revised November 20, 2016
  • Accepted November 25, 2016
  • First published January 24, 2017.
Online issue publication 
May 26, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you